TP53 was the most frequently mutated gene in our patient cohort and mutations in this gene were found in the tumors of 8 subjects: five patients diagnosed with osteosarcoma, one patient with alveolar rhabdomyosarcoma, one patient with Ewing sarcoma and other with solitary fibrous tumor (Table 3). This evidence concerns the gene TP53 and Ewing sarcoma.